Toxicity evaluation of gold-dendrimer composite nanodevices in vitro – difference found between tumour and proliferating endothelial cells

References

• Balogh, L, Swanson, DR, Spindler, R, Tomalia, DA. 1997. Formation and characterization of dendrimer-based water soluble inorganic nanocomposites. Proc ACS PMSE. pp, 118–119.
   Google Scholar
• Balogh L, Valluzzi R, Laverdure KS, Gido SP, Hagnauer GL, Tomalia DA. Formation of silver and gold dendrimer nanocomposites. J Nanoparticle Res 1999; 1: 353–368
   Web of Science ®Google Scholar
• Balogh L, Bielinska A, Eichman JD, Valluzzi R, Lee I, Baker JR, Lawrence TS, Khan MK. Dendrimer nanocomposites in medicine. Chimica Oggi (Chem Today) 2002; 20: 35–40
   Google Scholar
• Balogh L, Nigavekar SS, Nair BM, Lesniak W, Zhang C, Sung LY, Kariapper MST., et al. Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models. Nanomed: Nanotechnol, Biol Med 2007; 3: 281–296
   PubMed Web of Science ®Google Scholar
• Balogh LP, Khan MK. Dendrimer nanocomposites for cancer therapy. CRC Press/Taylor & Francis Group, Boca Raton, FL 2007
   Google Scholar
• Balogh LP, Nigavekar SS, Cook AC, Minc L, Khan MK. Development of dendrimer-gold radioactive nanocomposites to treat cancer microvasculature. PharmaChem 2003; 2: 94–99
   Google Scholar
• Bosman AW, Janssen HM, Meijer EW. About dendrimers: Structure, physical properties, and applications. Chem Rev 1999; 99: 1665–1688
   PubMed Web of Science ®Google Scholar
• Eichman JD, Bielinska AU, Kukowska-Latallo JF, Baker JR. The use of PAMAM dendrimers in the efficient transfer of genetic material into cells. Pharmaceut Sci Technol Today 2000; 3: 232–245
   PubMedGoogle Scholar
• Ely, TO, Sharma, M, Wojcieh, LG, Klippenstein, DL, Foster, BA, Balogh, LP. 2007. Dendrimer nanocomposites as multifunctional X-ray contrast agents. Materials Research Society Fall Meeting Quantum-Dot and Nanoparticle Bioconjugates – Tools for Sensing and Biomedical Imaging.Hynes Convention Center, Boston, MA.
   Google Scholar
• Hodge P. Polymer science branches out. Nature 1993; 362: 18–19
   Web of Science ®Google Scholar
• Hong S, Bielinska AU, Mecke A, Keszler B, Beals JL, Shi X, Balogh L, Orr BG, Baker JRJr, Banaszak Holl MM. Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport. Bioconjug Chem 2004; 15: 774–782
   PubMed Web of Science ®Google Scholar
• Jevprasesphant R, Penny J, Jalal R, Attwood D, McKeown NB, D'Emanuele A. The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int J Pharmaceut 2003; 252: 263–266
   PubMed Web of Science ®Google Scholar
• Khan MK, Nigavekar SS, Minc LD, Kariapper MST, Nair BM, Lesniak WG, Balogh LP. In vivo biodistribution of dendrimers and dendrimer nanocomposites – implications for cancer imaging and therapy. Technol Cancer Res Treatment 2005; 4: 603–613
   PubMed Web of Science ®Google Scholar
• Khan, MK, Nigavekar, SS, Minc, L, Nair, BM, Kariapper, MT, Lesniak, WG, Balogh, LP. 2006. Significant size-charge effects on the biodistribution of nanocomposites in a mouse tumor model system.Am Assoc Cancer Res Meeting Abstracts. 258b
   Google Scholar
• Khan MK, Minc LD, Nigavekar S, Kariapper MST, Nair BM, Schipper M, Cook AC, Lesniak WG, Balogh LP. Fabrication of radioactive gold/dendrimer composite nanodevices and their use for nanobrachytherapy. Nanomed: Nanotechnol, Biol Med 2008; 4: 57–69
   PubMed Web of Science ®Google Scholar
• Khandare J, Kolhe P, Pillai O, Kannan S, Lieh-Lai M, Kannan RM. Synthesis, cellular transport, and activity of polyamidoamine dendrimer-methylprednisolone conjugates. Bioconjugate Chem 2005; 2005: 330–337
   Google Scholar
• Kitchens KM, El-Sayed MEH, Ghandehari H. Transepithelial and endothelial transport of poly (amidoamine) dendrimers. Adv Drug Deliv Rev 2005; 57: 2163–2176
   PubMed Web of Science ®Google Scholar
• Kolhatkar RB, Kitchens KM, Swaan PW, Ghandehari H. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability. Bioconjugate Chem 2007; 18: 2054–2060
   PubMed Web of Science ®Google Scholar
• Lam CW, James JT, McCluskey R, Arepalli S, Hunte RL. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit Rev Toxicol 2006; 36: 189–217
   PubMed Web of Science ®Google Scholar
• Lesniak W, Bielinska AU, Sun K, Janczak KW, Shi X, Baker JR, Balogh LP. Silver/dendrimer nanocomposites as biomarkers: Fabrication, characterization, in vitro toxicity, and in-tracellular detection. Nano Lett 2005; 5: 2123–2130
   PubMed Web of Science ®Google Scholar
• Lesniak WG, Kariapper MST, Nair BM, Tan W, Hutson A, Balogh LP, Khan MK. Synthesis and characterization of PAMAM dendrimer-based multifunctional nanodevices for targeting αvβ3 integrins. Bioconjugate Chem 2007; 18: 1148–1154
   PubMed Web of Science ®Google Scholar
• Majoral JP, Caminade AM. Dendrimers containing heteroatoms (Si, P, B, Ge, or Bi). Chem Rev 1999; 99: 845–880
   PubMed Web of Science ®Google Scholar
• Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, Meijer EW, Paulus W, Duncan R. Dendrimers: Relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Release 2000; 65: 133–148
   PubMed Web of Science ®Google Scholar
• Maurice WPL, Baars A, Meijer EW. Dendrimers II. Architecture, Nanostructure Supramolec Chem 2000; 210: 131–182
   Google Scholar
• Myc A, Majoros IJ, Thomas TP, Baker JR., Jr. Dendrimer-based targeted delivery of an apoptotic sensor in cancer cells. Biomacromolecules 2007; 8: 13–18
   PubMed Web of Science ®Google Scholar
• Newkome GR, Moorefield CN, Vögtle F. Dendrimers and dendrons: Concepts, syntheses, applications. Wiley VCH, New York 2001
   Google Scholar
• Nigavekar SS, Sung LY, Llanes M, El-Jawahri A, Lawrence TS, Becker CW, Balogh L, Khan MK. 3H dendrimer nanoparticle organ/tumor distribution. Pharmaceut Res 2004; 21: 476–483
   PubMed Web of Science ®Google Scholar
• Quintana A, Raczka E, Piehler L, Lee I, Myc A, Majoros I, Patri AK, Thomas T, Mule J, Baker JR, Jr. Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res 2002; 19: 1310–1316
   PubMed Web of Science ®Google Scholar
• Roberts JC, Bhalgat MK, Zera RT. Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers. J Biomed Mater Res 1996; 30: 53–65
   PubMed Web of Science ®Google Scholar
• Seib FP, Jones AT, Duncan R. Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells. J Controlled Release 2007; 117: 291–300
   PubMed Web of Science ®Google Scholar
• Service RF. Science policy. Priorities needed for nano-risk research and development. Science 2006; 314: 45
   PubMed Web of Science ®Google Scholar
• Shukla R, Thomas TP, Peters JL, Desai AM, Kukowska-Latallo J, Patri AK, Kotlyar A, Baker JR, Jr. HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb. Bioconjugate Chem 2006; 17: 1109–1115
   PubMed Web of Science ®Google Scholar
• Smith CJ, Shaw BJ, Handy RD. Toxicity of single walled carbon nanotubes to rainbow trout, (Oncorhynchus mykiss): Respiratory toxicity, organ pathologies, and other physiological effects. Aquatic Toxicol 2007; 82: 94–109
   PubMed Web of Science ®Google Scholar
• Tan NB, Balogh L, Trevino S. Structure of metallo-organic nanocomposites produced from dendrimer complexes. Proc ACS Polymeric Materials: Science and Engineering 1997; 77: 120
   Google Scholar
• Thomas TP, Majoros IJ, Kotlyar A, Kukowska-Latallo JF, Bielinska A, Myc A, Baker JR, Jr. Targeting and inhibition of cell growth by an engineered dendritic nanodevice. J Medicinal Chem 2005; 48: 3729–3735
   PubMed Web of Science ®Google Scholar
• Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, Roeck J, Ryder J, Smith P. New class of polymers: Starbust-dendritic macromolecules. Polymer J 1984; 17: 117–132
   Web of Science ®Google Scholar
• Tomalia, DA, Balogh, L. 2003. Nanocomposites of dendritic polymers. US patent 6,664,315 B2.
   Google Scholar
• Tomalia, DA, Balogh, L. 2006. Nanocomposites of dendritic polymers. US patent 6,995,234.
   Google Scholar
• Tomalia DA, Reyna LA, Svenson S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem Soc Transact 2007; 35: 61–67
   PubMed Web of Science ®Google Scholar
• Witzmann FA, Monteiro-Riviere NA. Multi-walled carbon nanotube exposure alters protein expression in human keratinocytes. Nanomed: Nanotechnol, Biol Med 2006; 2: 158–168
   PubMed Web of Science ®Google Scholar
• Zheng L, Hulderman T, Salmen R, Chapman R, Leonard SS, Young S-H, Shvedova A, Luster MI, Simeonova PP. Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes. Environ Health Perspect 2007; 115: 377–382
   PubMed Web of Science ®Google Scholar